Row over study puts Korea's scientific community under scrutiny againApril 09, 2007Duplicate publication: A bitter dispute This week's BMJ investigates a bitter row over a scientific paper that is putting Korea's scientific community under scrutiny once again. The dispute has pitted a young Korean doctor, Jeong Hwan Kim, against Kwang Yul Cha, a fertility specialist and one of the most powerful players in the country's struggle for biotech supremacy, writes journalist Jonathan Gornall. It is also threatening to disrupt Korea's efforts to recover scientific credibility in the wake of the recent scandal over Woo-Sok Hwang's stem cell research.
Dr Kim claims a paper about premature ovarian failure that he originally published in the Korean Journal of Obstetrics and Gynaecology in January 2004 was translated and republished in the American journal Fertility and Sterility under a different title and with different authors in December 2005. What is indisputable is that Dr Kim's name was not present in the later version of the paper and that in his place as lead author was Dr Cha, his former employer and the head of CHA Health Systems, a "global healthcare enterprise" whose interests include the CHA Stem Cell Institute and several hospitals and clinics in Korea and the US. But the BMJ has learnt that the editor in chief of Fertility and Sterility has been threatened with legal action by Dr Cha, and that one of Dr Cha's co-authors on the disputed paper, Dr Sook Hwan Lee, has been charged with criminal copyright infringement. Dr Kim told the BMJ that the paper had begun life as his PhD thesis and that there were just two names on it when it was published by Korea University in May 2003. He then submitted this as a paper to the Korean Journal of Obstetrics and Gynaecology in July 2003 with five additional names, including Sook Hwan Lee. But his surprise turned to shock when, in December 2005, he saw a similar paper in Fertility and Sterility. He was even more shocked to see that the number of authors had reduced to six and that he was no longer one of them. The lead author was Dr Cha. In December last year, Dr Kim filed a lawsuit in Korea against Dr Cha and Dr Lee, alleging breach of copyright. Dr Lee responded by alleging that Dr Kim had defamed her. The CHA group also claims that Dr Kim stole the data used in the study. In February, the co-director of the CHA Stem Cell Institute, Professor Kwang Soo Kim, wrote to Fertility and Sterility to express regret about the incident. He explained how "our institution will serve a pivotal role in restoring the severely damaged reputation and credibility of stem cell and life science research in Korea after the Hwang scandal." Professor Kim's intervention leaves little doubt about how seriously the CHA group views the potential of the incident to damage its bid to inherit Hwang's crown, says Gornall. Before his fall from grace, Professor Hwang received the bulk of Korean government funding in stem cell research. But, in November last year, CHA Medical Group announced its plans to succeed Professor Hwang's now defunct World Stem Cell Hub by building Korea's largest stem cell institute on land provided by the Korean government. BMJ-British Medical Journal | |||||||||||||||||||||
|
Related Stem Cell Current Events and Stem Cell News Articles Children's Hospital scientists achieve repair of injured heart muscle in lab tests of stem cells Researchers at Children's Hospital of Pittsburgh of UPMC have been able to effectively repair damaged heart muscle in an animal model using a novel population of stem cells they discovered that is derived from human skeletal muscle tissue. Kidney function discovery sheds light on genetic complexity of disease To find a cure for cancer, haemophilia and other diseases, researchers need to be looking for complex, interacting genetic factors, according to the authors of a new study. Old flies can become young moms Female flies can turn back the biological clock and extend their lifespan at the same time, University of Southern California biologists report. Pure insulin-producing cells produced in mouse Singapore researchers have developed an unlimited number of pure insulin-producing cells from mouse embryonic stem cells (ESCs). Exercise increases brain growth factor and receptors, prevents stem cell drop in middle age A new study confirms that exercise can reverse the age-related decline in the production of neural stem cells in the hippocampus of the mouse brain, and suggests that this happens because exercise restores a brain chemical which promotes the production and maturation of new stem cells. Intraspinal implant of mesenchymal stem cells may not heal the demyelinated spinal cord Multiple sclerosis is a disease caused by the loss of the myelinated sheath surrounding the nerve fibers of the spinal cord. Stem Cells from Monkey Teeth Can Stimulate Growth and Generation of Brain Cells Researchers at the Yerkes National Primate Research Center, Emory University, have discovered dental pulp stem cells can stimulate growth and generation of several types of neural cells. Findings from this study, available in the October issue of the journal Stem Cells, suggest dental pulp stem cells show promise for use in cell therapy and regenerative medicine, particularly therapies associated with the central nervous system. Stanford research sheds light on key trigger of embryonic stem cell differentiation Clusters of mouse embryonic stem cells called embryoid bodies more closely approximate true embryos in organization and structure than previously thought, according to researchers at the Stanford University School of Medicine. Harnessing the signals that influence the cells' fate may help researchers more accurately direct the differentiation of embryonic stem cells for use in therapy. Scripps research scientists identify compounds for stem-cell production from adult cells In the study, the scientists screened known drugs and identified small molecules that could replace conventional reprogramming genes, which can have dangerous side effects. 'Junk' DNA proves functional In a paper published in Genome Research on Nov. 4, scientists at the Genome Institute of Singapore (GIS) report that what was previously believed to be "junk" DNA is one of the important ingredients distinguishing humans from other species. More Stem Cell Current Events and Stem Cell News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||